Come up with a name for your new list and we'll add to it:
Immunologix raised a round of funding on November 17, 2010. Investors include
Qualifying Therapeutic Discovery Project.
Immunologix is a human antibody development company founded on a proprietary technology that transforms naive B-cells into fully human monoclonal antibodies targeting any antigen. In October 2011, Im…